Cartoon-style liver receiving cholesterol gene editing nanoparticles lowers LDL and triglycerides.

A One-and-Done Shot for Cholesterol? Gene Editing Moves Beyond Rare Diseases

A small trial used gene editing to switch off a liver gene and cut harmful blood fats by about half. Here’s how a “one-and-done” cholesterol treatment could work—and how the NHS might use it if larger studies prove safe and effective.

Continue reading